SUPPLEMENTARY INFORMATION
FROM:
Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
K Zhou, L Donnelly, L Burch, R Tavendale, A S F Doney, G Leese, A T Hattersley, M I McCarthy, A D Morris, C C Lang, C N A Palmer and E R Pearson
BACK TO ARTICLEDownload plugins